WHO
-
Semaglutide Medicine Discovered to Contribute in Significant Weight Loss for Adults with Obesity
An international clinical trial showed that a once-weekly treatment of semaglutide helped in weight loss among obese adults.
Latest Research Articles
-
TB Strains Confirmed from Ancient DNA of Marine Mammals and Humans in Peru During Pre-Colonial Period
-
This Molecule Plays a Crucial Role Against Inflammation and Weight Gain in Obesity: New Study
-
Scientists Explore How This Bacteria Uses Mirror Image to Cause Antibiotic Resistance
-
Guinea Worm Disease Nears Eradication; Lowest Cases Recorded in 2021
-
'Historic Day': WHO Initiates Widespread Rollout of First-Ever Malaria Vaccine in Africa
-
Air Pollution Causes 7 Million Deaths Yearly, Prompting WHO to Strengthen Guidelines
-
Fake Pfizer Covid Vaccines Found in Poland and Mexico Due to Increasing Demand
-
WHO: No Live Coronavirus Found in Breastmilk, Breastfeeding still Recommended
-
WHO: At Least 70 Candidate Vaccines Against Coronavirus, Under Development
CDC, WHO, and Biotech Companies: The Critical Need for Quicker Coronavirus Testing
-
WHO: Ignorance, Mistrust Risk Ebola Resurgence in Congo
Climate Change Can Worsen Ebola Crisis
MOST POPULAR
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
-
Enjoying Nature: How Outdoor Activities Can Benefit Children & Teens
-
Texas Woman Hopped on a Kayak to Escape Floodwaters With Her Dogs: 'I'm Still in Shock'
-
How Gene Editing Could Save Endangered Species from Extinction
